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Introduction
Cutaneous graft-versus-host-disease (GVHD) is a common
manifestation of GVHD post allogeneic haematopoietic
stem cell transplantation (HSCT). It is characterised into
lichenoid and scleroderma variants. Sclerodermatous
GVHD is thought to be rare, with few reports in the
paediatric population.
Objectives
To describe 3 paediatric cases of GVHD associated
scleroderma.
Methods
Retrospective case note review.
Results
A 7 year old girl was referred to rheumatology 2 years
after maternal HLA matched HSCT for acute lympho-
blastic leukaemia. Mild cutaneous GVHD was noted
post transplant. She subsequently presented with severe
sclerodermatous changes on both lower legs. She had
marked loss of range of movement (ROM) of her ankles,
and the disease rapidly progressed to involve the skin of
her thighs and left arm, with significant joint contractures.
She was treated with methylprednisolone, methotrexate
and physiotherapy (PT) with good effect: improved ROM,
softening of the skin and no further progression.
A 4 year old girl was referred to rheumatology 3 years
after having 2 matched sibling HSCT for MHC class 2
deficiency. Very mild cutaneous GVHD had been noted
post transplant. She presented with rapidly worsening
contractures affecting her hands and lower limbs with
diffuse swelling, erythema, thickness and tethering of
skin and tendons. She was treated with PT, occupational
therapy (OT) and splinting, together with prednisolone
and methotrexate. Clinical improvement was maintained
over the following year.
A 6 year old girl with beta thalassaemia major was
referred to rheumatology 2 years post HSCT. Buccal
GVHD was noted 4 months post transplant, treated
initially with steroids and ciclosporin followed by extra-
corporeal photophoresis. Despite some initial response
to this there was a profound deterioration of hand func-
tion with severely restricted wrists and fingers bilaterally
and reduced grip strength. She has been treated with an
increased dose of prednisolone, the addition of metho-
trexate, PT and OT.
Discussion
We report 3 cases of sclerodermatous GVHD following
HSCT. The indications for HSCT differed in each case.
All had mild cutaneous GVHD noted in the early post
transplant period. All presented months or years later
with extensive sclerodermatous skin changes. Wide-
spread established joint contractures were noted at the
time of referral to rheumatology. There is a paucity of
evidence regarding effective treatment for this condition.
2 of our cases showed significant improvement with a
combination of steroids, methotrexate, PT, OT and
appropriate splinting.
Conclusion
Sclerodermatous GVHD is rare in the paediatric popula-
tion but results in significant morbidity in affected indivi-
duals. In these cases severe joint contractures were noted
at the time of referral to Rheumatology. Monitoring for
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early signs of joint contracture post HSCT, and raising
awareness of this potential complication, should facilitate
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